Pharmacy

Your Article Summary

See Latest Articles

HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials
Abbott, 05/08/09

The Abbott RealTime HIV-1 Assay and Abbott m2000 System have been recommended as a standard protocol for viral load testing in HIV/AIDS clinical trials sponsored by the National Institutes of Health . This recommendation was made by the Cross-Network Laboratory Focus Group (LFG), which consists of representatives from five of the NIH-sponsored HIV/AIDS clinical trials networks. The LFG recently issued a consensus statement, which was reviewed and approved by the leadership of the five networks, recommending the use of the Abbott RealTime HIV-1 assay and m2000 system for upcoming clinical trials in 2009 and beyond that have a primary focus on viral load measurements.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Two Drugs Fail in Trials
PharmExec, 03/11/10

Bristol-Myers Squibb and AstraZeneca announce the commencement of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus Trial
AstraZeneca, 03/10/10

Gynecologic Oncology Group Notifies CTI That Continuation of GOG-212 Pivotal Trial of OPAXIO Maintenance Therapy in Front Line Ovarian Cancer Remains High Priority
Cell Therapeutics, 03/08/10

 See all of Drug Trials

Today in Major Studies...keeping you current

Receive free subspecialty "5-minute updates" via email

A pilot study to evaluate a community pharmacy–based monitoring system to identify adverse drug reactions associated with paediatric medicines use
European Journal of Clinical Pharmacology, 03/05/10

Lancet retracts 12-year-old study linking autism to measles-mumps-rubella vaccine
American Pharmacists Association, 03/02/10

Disease-modifying antirheumatic drugs prove most cost-effective in very early RA
Formulary , 03/02/10

 See all of Major Studies